The researcher belonging to University of Nebraska Medical Center College of Pharmacy has discovered a new powerful anti-malaria drug SynriamTM, which is very effective as compared to traditional anti-malaria drugs like Chloroquine, Quinine and Mefloquine etc. which are partially ineffective against deadly malaria parasite. In the developed countries a mosquito bite seems harmless but in developing countries like India it causes more than 200,000 deaths per year mostly in children. Developed by Ranbaxy Pharmaceuticals Limited, the drug has been approved by the Indian government for treatment of malaria in adults. The company is working hard to develop its children’s formula and is damn sure that the children version of the drug will be available soon in upcoming days.
Unlike other traditional anti-malaria drugs, it’s cheaper, more effective and has lesser side effects and does not have to be taken after food. It’s three days dose with one tab per day is quite sufficient to eliminate the malaria from human body.
Meet the Researcher : Dr. Vennerstrom
The full credit for this ultimate invention goes to Dr.Vennerstorm and his team. We should say thanks to them for their hardwork and dedication that led to the development of SynriamTM. Dr. Vennerstrom Ph.D is currently working as a professor at the UNMC (University of Nebraska Medical Center) College of Pharmacy. He has been studying malaria for more than 25 years.
The finance for this project around USD $12 was provided by Medicines for Malaria Venture (MMV), a non-profit organization in Geneva. The research team included scientists at the Swiss Tropical and Public Health Institute in Switzerland and Monash University in Australia.
Speaking about this project, Dr. Vennerstrom said :
Watch Exclusive Video – Ranbaxy announces to produce SynriamTM
Watch this exclusive video when famous drug and medicine manufacturer Ranbaxy announced to produce SynriamTM, India’s first new drug.